Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2018 February;70(1) > Minerva Pediatrica 2018 February;70(1):67-78

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,764


eTOC

 

REVIEW  


Minerva Pediatrica 2018 February;70(1):67-78

DOI: 10.23736/S0026-4946.17.05131-3

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Antithrombotic treatment in neonates and children

C. Heleen van OMMEN

Department of Pediatric Hematology, Sophia Children’s Hospital ErasmusMC, Rotterdam, The Netherlands


PDF  


Despite the increasing incidence of venous thromboembolic disease in pediatric patients, it remains a rare complication in childhood. Particularly neonates and adolescents are at risk for development of venous thrombosis. Spontaneous thrombotic events are sporadic, the majority of children have multiple coexisting risk factors, including central venous catheter, asphyxia, congenital heart disease, infection, malignancy, surgery and hypovolemia. Most thrombi are diagnosed by ultrasonography. Recommendations for management of pediatric thrombosis are typically extrapolated from adult studies, despite many differences between adults and children, including developmental hemostasis. This review will focus on the management of venous thrombosis in neonates and children, and discuss the use of the available antithrombotic agents in both age categories with reference to those differences.


KEY WORDS: Venous thrombosis - Anticoagulants - Thrombolytic therapy

top of page

Publication History

Issue published online: January 12, 2018
Article first published online: November 21, 2017
Manuscript accepted: November 13, 2017
Manuscript received: November 4, 2017

Cite this article as

van Ommen CH. Antithrombotic treatment in neonates and children. Minerva Pediatr 2018;70:67-78. DOI: 10.23736/S0026-4946.17.05131-3

Corresponding author e-mail

c.vanommen@erasmusmc.nl